Dear Dr. Renukaprasad A R, The preferred treatment for renal cell carcinoma has evolved over the years from cytokine-based therapy to immune-checkpoint inhibitors and combination therapy. Considering patient history, disease progression, and biochemical test results while designing the treatment strategy can greatly improve patient outcomes. Join us for an insightful session as Dr. Nikhil Krishna Haridas shares his expertise on "Systemic Therapy: Selecting First-line Therapy and Later-line Therapy", Today at 3:00 PM IST. |
No comments:
Post a Comment